-
1
-
-
0034516930
-
Effect of sibutramine on weight maintenance after weight loss: A randomised trial
-
STORM Study Group. Sibutramine trial of obesity reduction and maintenance
-
James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance. Lancet 2000; 356: 2119-2125.
-
(2000)
Lancet
, vol.356
, pp. 2119-2125
-
-
James, W.P.1
Astrup, A.2
Finer, N.3
-
2
-
-
0035913584
-
Long-term weight loss with sibutramine: A randomized controlled trial
-
Wirth A, Krause J. Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286: 1331-1339. (Pubitemid 33015524)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.11
, pp. 1331-1339
-
-
Wirth, A.1
Krause, J.2
-
3
-
-
0034520443
-
Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: A randomised, double-blind, placebo-controlled study
-
DOI 10.1046/j.1463-1326.2000.00071.x
-
Finer N, Bloom SR, Frost GS, et al. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab 2000; 2: 105-112. (Pubitemid 33072165)
-
(2000)
Diabetes, Obesity and Metabolism
, vol.2
, Issue.2
, pp. 105-112
-
-
Finer, N.1
Bloom, S.R.2
Frost, G.S.3
Banks, L.M.4
Griffiths, J.5
-
4
-
-
0038510366
-
A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin
-
Multicenter Sibutramine Study Group
-
McNulty SJ, Ur E, Williams G; Multicenter Sibutramine Study Group. A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care 2003; 26: 125-131.
-
(2003)
Diabetes Care
, vol.26
, pp. 125-131
-
-
McNulty, S.J.1
Ur, E.2
Williams, G.3
-
5
-
-
0008084861
-
Weight loss produced by sibutramine: A metaanalysis
-
Astrup A, Chong E. Weight loss produced by sibutramine: a metaanalysis. Int J Obes Relat Metab Disord 2001; 25(Suppl 2): S104.
-
(2001)
Int J Obes Relat Metab Disord
, vol.25
, Issue.SUPPL. 2
-
-
Astrup, A.1
Chong, E.2
-
6
-
-
0034516930
-
Efficacy of sibutramine on weight maintenance after weight loss: A randomised trial
-
The STORM Study Group
-
James WS, Astrup A, Finer N, et al. Efficacy of sibutramine on weight maintenance after weight loss: a randomised trial: The STORM Study Group. Lancet 2000; 356: 2119-2125.
-
(2000)
Lancet
, vol.356
, pp. 2119-2125
-
-
James, W.S.1
Astrup, A.2
Finer, N.3
-
7
-
-
0036733520
-
Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction
-
Zannad F, Gille B, Grentzinger A, et al. Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction. Am Heart J 2002; 144: 508-515.
-
(2002)
Am Heart J
, vol.144
, pp. 508-515
-
-
Zannad, F.1
Gille, B.2
Grentzinger, A.3
-
9
-
-
27744466523
-
The SCOUT study: Risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients
-
James WPT. The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients. Eur Heart J Suppl 2005; 7(Suppl L): L44-L48.
-
(2005)
Eur Heart J Suppl
, vol.7
, Issue.SUPPL. L
-
-
James, W.P.T.1
-
10
-
-
77952756208
-
Does the risk profile of patients with cardiovascular disease and/or diabetes modify initial response to treatment with sibutramine? A preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial
-
on behalf of the SCOUT Investigators. Abstract T2:PS:80 available at
-
Caterson I, Sharma AM, Coutinho W, et al.; on behalf of the SCOUT Investigators. Does the risk profile of patients with cardiovascular disease and/or diabetes modify initial response to treatment with sibutramine? A preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial. Int J Obes 2008; 32(Suppl 1s): S100, Abstract T2:PS:80 (available at: www.nature.com/ijo/journal/v32/n1s/pdf/ijo200847a.pdf).
-
(2008)
Int J Obes
, vol.32
, Issue.SUPPL. 1S
-
-
Caterson, I.1
Sharma, A.M.2
Coutinho, W.3
-
11
-
-
65549167028
-
The obesity paradox, weight loss, and coronary disease
-
12 Aug [epub ahead of print]
-
Lavie CJ, Milani RV, Artham SM, et al. The obesity paradox, weight loss, and coronary disease. Am J Med 12 Aug 2009 [epub ahead of print].
-
(2009)
Am J Med
-
-
Lavie, C.J.1
Milani, R.V.2
Artham, S.M.3
-
12
-
-
67651096062
-
Explaining the obesity paradox: Cardiovascular risk, weight change, and mortality during long-term follow-up in men
-
Strandberg T, Strandberg A, Salomaa V, et al. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men. Eur Heart J 2009; 30: 1720-1727.
-
(2009)
Eur Heart J
, vol.30
, pp. 1720-1727
-
-
Strandberg, T.1
Strandberg, A.2
Salomaa, V.3
-
13
-
-
75749148775
-
Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years
-
McAuley PA, Kokkinos PF, Oliveira RB, et al. Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years. Mayo Clin Proc 2010; 85(2): 115-121.
-
(2010)
Mayo Clin Proc
, vol.85
, Issue.2
, pp. 115-121
-
-
McAuley, P.A.1
Kokkinos, P.F.2
Oliveira, R.B.3
-
14
-
-
77649154704
-
Obesity paradox or reverse epidemiology
-
Epub 23 Feb 2010
-
Dorner TE, Rieder A. Obesity paradox or reverse epidemiology. Dtsch Med Wochenschr 2010; 135(9): 413-418. [Epub 23 Feb 2010.]
-
(2010)
Dtsch Med Wochenschr
, vol.135
, Issue.9
, pp. 413-418
-
-
Dorner, T.E.1
Rieder, A.2
|